These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target. Alvisi G; Termanini A; Soldani C; Portale F; Carriero R; Pilipow K; Costa G; Polidoro M; Franceschini B; Malenica I; Puccio S; Lise V; Galletti G; Zanon V; Colombo FS; De Simone G; Tufano M; Aghemo A; Di Tommaso L; Peano C; Cibella J; Iannacone M; Roychoudhuri R; Manzo T; Donadon M; Torzilli G; Kunderfranco P; Di Mitri D; Lugli E; Lleo A J Hepatol; 2022 Nov; 77(5):1359-1372. PubMed ID: 35738508 [TBL] [Abstract][Full Text] [Related]
3. Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma. Murakami T; Tanaka N; Takamatsu K; Hakozaki K; Fukumoto K; Masuda T; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Sawada K; Imamura T; Mizuno R; Oya M Cancer Immunol Immunother; 2021 Oct; 70(10):3001-3013. PubMed ID: 34259900 [TBL] [Abstract][Full Text] [Related]
4. Immune profiling identifies CD8 Chen Z; Guo ML; Li YY; Yan K; Li L; Shen F; Guan H; Liu QZ; Xu B; Lian ZX Front Immunol; 2022; 13():894919. PubMed ID: 36420264 [TBL] [Abstract][Full Text] [Related]
5. Anti-PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in Mice. Wabitsch S; Tandon M; Ruf B; Zhang Q; McCallen JD; McVey JC; Ma C; Green BL; Diggs LP; Heinrich B; Greten TF Cell Mol Gastroenterol Hepatol; 2021; 12(3):1166-1178. PubMed ID: 34033968 [TBL] [Abstract][Full Text] [Related]
6. Intratumoral CD39 Yeong J; Suteja L; Simoni Y; Lau KW; Tan AC; Li HH; Lim S; Loh JH; Wee FYT; Nerurkar SN; Takano A; Tan EH; Lim TKH; Newell EW; Tan DSW J Thorac Oncol; 2021 Aug; 16(8):1349-1358. PubMed ID: 33975004 [TBL] [Abstract][Full Text] [Related]
7. Location of CD39 Koppensteiner L; Mathieson L; Pattle S; Dorward DA; O'Connor R; Akram AR J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37648263 [TBL] [Abstract][Full Text] [Related]
8. Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses. Xia T; Li K; Niu N; Shao Y; Ding D; Thomas DL; Jing H; Fujiwara K; Hu H; Osipov A; Yuan C; Wolfgang CL; Thompson ED; Anders RA; He J; Mou Y; Murphy AG; Zheng L J Hematol Oncol; 2022 Mar; 15(1):37. PubMed ID: 35346322 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers of tumor-reactive CD4 Palomero J; Panisello C; Lozano-Rabella M; Tirtakasuma R; Díaz-Gómez J; Grases D; Pasamar H; Arregui L; Dorca Duch E; Guerra Fernández E; Vivancos A; de Andrea CE; Melero I; Ponce J; Vidal A; Piulats JM; Matias-Guiu X; Gros A J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36581331 [TBL] [Abstract][Full Text] [Related]
10. Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer. Laumont CM; Wouters MCA; Smazynski J; Gierc NS; Chavez EA; Chong LC; Thornton S; Milne K; Webb JR; Steidl C; Nelson BH Clin Cancer Res; 2021 Jul; 27(14):4089-4100. PubMed ID: 33963000 [TBL] [Abstract][Full Text] [Related]
11. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma. Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865 [TBL] [Abstract][Full Text] [Related]
12. Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma. Song G; Shi Y; Meng L; Ma J; Huang S; Zhang J; Wu Y; Li J; Lin Y; Yang S; Rao D; Cheng Y; Lin J; Ji S; Liu Y; Jiang S; Wang X; Zhang S; Ke A; Wang X; Cao Y; Ji Y; Zhou J; Fan J; Zhang X; Xi R; Gao Q Nat Commun; 2022 Mar; 13(1):1642. PubMed ID: 35347134 [TBL] [Abstract][Full Text] [Related]
13. Systematic profiling of mitochondria-related transcriptome in tumorigenesis, prognosis, and tumor immune microenvironment of intrahepatic cholangiocarcinoma: a multi-center cohort study. Chen B; Lu M; Chen Q; Zou E; Bo Z; Li J; Zhao R; Zhao J; Yu Z; Chen G; Wu L Front Genet; 2024; 15():1430885. PubMed ID: 39130746 [TBL] [Abstract][Full Text] [Related]
14. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA. Wang C; Chen C; Hu W; Tao L; Chen J Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206 [TBL] [Abstract][Full Text] [Related]
15. Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy. Attrill GH; Owen CN; Ahmed T; Vergara IA; Colebatch AJ; Conway JW; Nahar KJ; Thompson JF; Pires da Silva I; Carlino MS; Menzies AM; Lo S; Palendira U; Scolyer RA; Long GV; Wilmott JS J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688560 [TBL] [Abstract][Full Text] [Related]
16. Correlation of Vein-Rich Tumor Microenvironment of Intrahepatic Cholangiocarcinoma With Tertiary Lymphoid Structures and Patient Outcome. Doi N; Ino Y; Fuse M; Esaki M; Shimada K; Hiraoka N Mod Pathol; 2024 Feb; 37(2):100401. PubMed ID: 38043787 [TBL] [Abstract][Full Text] [Related]